Hetero's application for generic version of Sputnik Light Covid-19 vaccine to be taken up by SEC today

If approved, Hetero Biopharma will be the first company to receive approval for the generic version. “The company will present the data of its trials,” a person in the know told ET. Earlier this month, the Drugs Controller General of India (DCGI) granted emergency use authorisation for the single-dose Sputnik Light vaccine in the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QxtLlPV
via IFTTT